| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Timing of delivery and induction.

Slides:



Advertisements
Similar presentations
 may be efective in preventing SGA birth in women at high risk of preeclampsia although the effect size is small. (c)
Advertisements

The ACOG Task force on hypertension in pregnancy
Hypertensive Disorder in Pregnancy
HYPERTENSIVE DISORDERS OF PREGNANCY Dr. Dianne MP Graham, MD, CCFP Based on Guidelines From SOGC ALARM Course & WHO Guide on Managing Complications in.
Improving Birth Outcomes Rebekah E. Gee, MD MPH MSHPR FACOG.
Systemic Lupus Erythematosus and Pregnancy:An Overview
 Discuss why pregnant adolescents are considered high risk  Special Considerations in regards to  Use of force  Restraints  Transportation  Substance.
HYPERTENSIVE DISEASE IN PREGNANCY WITH ASSOCIATED NEONATAL OUTCOMES
Diabetes and Pregnancy
VITAL STATISTICS AIM : To reduce maternal, fetal and neonatal deaths related to pregnancy and labour by evaluating the data and taking measures to prevent.
OXYTOCIN It is an octapeptide synthesized in hypothalamus and stored in pituitory. Trade name:  Pitocin, Syntocinon(1 amp= 1 ml= 5 IU)
Headache, Blurred Vision, Convulsions, Loss of Consciousness or Elevated Blood Pressure Advances in Maternal and Neonatal Health.
 To educate pregnant women on the importance of prenatal care and educate them on the complications that pertain to human pregnancy.  To be knowledgeable.
Factors associated with perinatal deaths in women delivering in a health facility in Malawi Lily C. Kumbani, Johanne Sundby and Jon Øyvind Odland.
Active Management of Third Stage of Labor
Preventing Elective Deliveries Before 39 Weeks John R. Allbert Charlotte, NC.
Hypertension in Pregnancy Updates: ACOG Task Force 2013.
Diseases and Conditions of Pregnancy pre-eclampsia once called toxemia –a pregnancy disease in which symptoms are –hypertension –protein in the urine –Swelling.
Obstetrical team of the « Mother-Child » College Members: L.Decatte J.M. Foidart C. Hubinont C. Kirkpatrick D. Leleux M. Temmerman F. Van Assche J. Van.
TEMPLATE DESIGN © Diet Plus Insulin Compared to Diet Alone In The Treatment of GDM Mothers in HUSM, Kelantan. Wan Faizah.
05_XXX_MM1 MATERNAL AND PERINATAL RESEARCH José Villar, Mariana Widmer, Mario Merialdi, Archana Shah for the WHO Maternal and Perinatal Research Network.
Premature Delivery Premature Rupture of Membrane Prolonged Pregnancy, Multiple Pregnancy Women Hospital, School of Medical, ZheJiang University Yang Xiao.
Keeping the ‘Normal’ in Normal Birth Interdisciplinary Panel Discussion November 30 th, 2006.
GEORGIA HOSPITAL ENGAGEMENT NETWORK (GHEN)
Preterm labor.
POST TERM PREGNANCY & IOL Dr. Salwa Neyazi Assistant professor and consultant OBGYN KSU Pediatric and adolescent gynecologist.
Management of severe hypertension.  For women with persistent chronic hypertension with SBP >160 or DBP >105, start antihypertensive therapy  Maintain.
POST TERM SALWA NEYAZI ASSISTANT PROF.& CONSULTANT OBGYN KSU.
Max Brinsmead MB BS PhD May Definition and Incidence  Prolonged pregnancy is defined as that proceeding beyond 42 weeks gestation  In the absence.
TEMPLATE DESIGN © UNSCHEDULED ADMISSIONS AND DELIVERY IN WOMEN WITH PRIOR CAESAREAN BIRTH AND PLANNED FOR DELIVERY BY.
TIME OF DELIVERY IN HYPERTENSIVE DISORERS OF PREGNANCY Laleh Eslamian MD. Prof. of Obstet & Gynecol Perinatologist, Shariati hospital, TUMS.
POSTTERM PREGNANCY: THE IMPACT ON MATERNAL AND FETAL OUTCOME Dr. Hussein. S. Qublan- Al-Hammad Jordanian Board in Obstet &Gynecology European Board in.
Preterm Labor & Preterm Birth Family Medicine Specialist CME Vientiane, Lao PDR December 10 – 12, 2008.
GROUP 5 YUSUF SELAWIJAYA YUSUF SELAWIJAYA DHADHANG SETYA DHADHANG SETYA COKORDA GEDE ARI.D COKORDA GEDE ARI.D GUNGDE INDRA GUNGDE INDRA GABRIEL RENATA.
1 |1 | Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 WHO Recommendations for the.
Aspirin for Pre- eclampsia? Max Brinsmead MB BS PhD July 2015.
Diabetes in pregnancy Timing and Mode of Delivery
HYPERTENSIVEDISORDERS OF PREGNANCY. Pregnancy Induced Hypertension Hypertension/ or Proteinuria developing after 20 weeks of pregnancy, during labour.
DR. MASHAEL AL-SHEBAILI OBSTETRICS & GYNAECOLOGY DEPARTMENT
Global Evidence for the Use of Calcium for PE/E Prevention Jeffrey Michael Smith, MD, MPH Jhpiego / Johns Hopkins University Maternal Health Team Leader.
The evidence for going to scale with Calcium supplementation Harshad Sanghvi Vice-President & Medical Director, Jhpiego Senior Advisor, Accelovate/USAID,
Induction of labour practice recommendations Dr. Mohammed Abdalla Egypt, Domiat G. Hospital.
ORAL ANTIHYPERTENSIVE THERAPY FOR SEVERE HYPERTENSION IN PREGNANCY AND POSTPARTUM: A SYSTEMATIC REVIEW Tabassum FirozLaura Magee Karen MacDonellBeth Payne.
Dr. Hythem Al-Sum Consultant Obstetrics, ICU, MFM MNGHA KAMC-RD.
Hypnosis Antenatal Training for Childbirth (HATCh): a randomised controlled trial A.M Cyna, C.A Crowther, J.S Robinson, M.I Andrew, G Antoniou, P Baghurst.
MANDATE Maternal and Neonatal Directed Assessment of Technology GBCHealth November 29, 2011.
Breech presentation.
UOG Journal Club: June 2016 Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancy outcome (SAFE trial):
Hypertensive Disorders of Pregnancy - Dr Thomas Carins
UOG Journal Club: March 2016
UOG Journal Club: June 2016 Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancy outcome (SAFE trial):
DIP, GDM; CLINICAL IMPORTANCE AND NEW WHO DIAGNOSTIC CRITERIA FOR GDM
HYPERTENSIVE DISORDERS OF PREGNANCY
MATERNITY WARD NPH.
Preliminary results of a randomized study on double-balloon catheter versus dinoprostone vaginal insert for induction of labor with an unfavorable cervix.
NICE guidelines for management of labour: First stage of labour
Pre-eclampsia Matthew Beaumont.
James M. Roberts, M.D., Leslie Myatt, Ph.D.,et al.
Preeclampsia: an overview
Tabassum Firoz MD MSc FRCPC University of British Columbia
Maternal health and the health of Australian Babies
Autoimmune disease in pregnancy
A. Khan, V. R. N. Ramoutar, B. Bassaw
Gestational Diabetes Lab 4.
WHO recommendations on interventions to improve preterm birth outcomes
Chronic Hypertension If controlled hypertension, not recommended to deliver before 38 weeks Changes if uncontrolled and especially if growth restriction.
Induction of labor (IOL)
Obstetric Cholestasis (lntrahepatic cholestasis of pregnancy):
Dr. MSc. Raul Hernandez Canete
Nat. Rev. Nephrol. doi: /nrneph
Presentation transcript:

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Timing of delivery and induction in pre-eclampsia Matthews Mathai

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Principles of Management Pre-eclampsia affects both the mother and the fetus Multisystem disorder Elevated blood pressure and proteinuria are among the many other findings Only definitive treatment for pre-eclampsia is the delivery of the baby and the placenta

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Timing of delivery Fetal considerations –Prematurity –Stillbirth Hypoxia Placental abruption –Newborn asphyxia Maternal considerations –Worsening of disease Complications

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Timing of delivery Mild or severe disease? –Early delivery with severe disease Preterm or term? –Delivery more likely if term

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Timing based on severity of disease "Severe pre-eclampsia and eclampsia are managed similarly with the exception that delivery must occur within 12 hours of onset of convulsions in eclampsia. ALL cases of severe pre-eclampsia should be managed actively" –Managing Complications in Pregnancy and Childbirth, 2000

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Expectant care for severe pre-eclampsia before term? Cochrane review: Churchill & Duley (2002) Two trials – South Africa & USA; 133 women Women had h period of stabilization –Steroids, magnesium sulphate and antihypertensives, if necessary –Randomized if eligibility criteria met Interventionist group – induction/CS Expectant: delivery at 34 wk or earlier if deterioration

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Expectant care for severe pre-eclampsia before term? Insufficient data for reliable conclusions on maternal adverse outcomes, stillbirths and newborn deaths –Eclampsia, renal failure, pulmonary oedema, HELLP syndrome, CS, placental abruption Interventionist group had –More HMD RR 2.3 (95% CI ) –More NEC RR 5.54 (95% CI ) –More likely to need NICU admission RR 1.32 (95% CI ) –Less likely to be SGA RR 0.36 ( )

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Expectant care for severe pre-eclampsia before term? Authors' conclusion –"There are insufficient data for any reliable recommendation about which policy of care should be used for women with severe early onset pre-eclampsia. Further large trials are needed." Global context for consideration –Availability of NICU facilities –Accessibility –Costs of care –Long term survival

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Timing based on severity of disease "In severe pre-eclampsia, delivery should occur within 24 hours of the onset of symptoms" –Managing Complications in Pregnancy and Childbirth, 2000

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Delivery in mild pre-eclampsia Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial –Koopmans et al, Lancet 2009; 374: –756 women with singleton pregnancies at weeks –Primary outcome: Composite measure of poor maternal outcome Death, eclampsia, HELLP syndrome, pulmonary oedema, thromboembolic disease, abruption, progression to severe hypertension or proteinuria, PPH > 1L

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Delivery in mild pre-eclampsia Induction group (n=377) –Induced within 24 h of randomization –ARM + oxytocin if Bishop score > 6 –Cervical ripening with PG or balloon catheter if score < 6 Expectant group (n=379) –Monitoring with frequent monitoring of BP, proteinuria, fetal health status. –Induce if worsening of disease, PROM > 48 h, fetal distress or gestation > 41 wk –Koopmans et al, Lancet 2009; 374:

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Delivery in mild pre-eclampsia 117 (31%) of women allocated to induction of labour developed poor maternal outcome compared to 166 (44%) allocated to expectant monitoring (RR 0.71; 95% CI ) No cases of maternal or neonatal death or eclampsia reported "Induction of labour is associated with improved maternal outcome and should be advised for women with mild hypertensive disease beyond 37 weeks' gestation." –Koopmans et al, Lancet 2009; 374:

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Induction techniques - Summaries Recommended: –Oral misoprostol 25 mcg every 2 h –Low dose vaginal misoprostol 25 mcg every 6 h –Low does vaginal prostaglandins –Balloon catheter –Combination of balloon catheter plus oxytocin as an alternative method when PGs (including misoprostol) are not available or contraindicated –Oral or vaginal misoprostol for IUD in third trimester –Sweeping membranes for reducing formal induction of labour WHO recommendations for induction of labour 2011

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Induction techniques - Summaries Not recommended –Amniotomy alone –Misoprostol in women with previous caesarean section WHO recommendations for induction of labour 2011

| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Current recommendations Deliver within 24 h for severe pre- eclampsia Expectant management with monitoring for mild pre-eclampsia until 36 wk; induce labour after 37 wk Induction methods include amniotomy, oxytocin, prostaglandins including misoprostol and balloon catheter –Managing Complications in Pregnancy and Childbirth, 2000